Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 16Thyroid Cancer, Papillary 8Adenocarcinoma, Follicular 8Thyroid Nodule 1Thyroid Diseases 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Low Risk Differentiated Thyroid Cancer 1Leukemia, Myelomonocytic, Chronic 1Infertility 1Hyperthyroidism 1Hodgkin Disease 1Head and Neck Neoplasms 1Differentiated Thyroid Cancer 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Sorafenib 3selpercatinib 2cabozantinib 2Thyroid (USP) 2Sodium 2Radiofrequency Ablation 2Metformin 2vandetanib 1tomivosertib 1temsirolimus 1repotrectinib 1pralsetinib 1pembrolizumab 1lenvatinib 1binimetinib 1apatinib 1acetaminophen, codeine drug combination 1Vitamin B 12 1Tramadol 1Thyroxine 1Thyrotropin-Releasing Hormone 1Technetium Tc 99m Sestamibi 1Surgical Procedures, Operative 1Pemetrexed 1Panobinostat 1Negative-Pressure Wound Therapy 1NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1Lysine Acetyltransferase 5 1Iodine-131 1Folic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thyroid Diseases × Iodine-131 × Clear all
NCT00673010 2025-10-09

Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
20 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡